723
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy

, , MD, , , , , , , , & show all
Pages 735-744 | Received 23 Feb 2007, Accepted 30 May 2007, Published online: 07 Jul 2009

Figures & data

Figure 1. Maternal serum concentrations of CXCL10/IP-10 in patients with normal pregnancies and those with pyelonephritis. The median serum concentration of CXCL10/IP-10 in pregnant patients with pyelonephritis was significantly higher than in normal pregnant women (median 318.5 pg/mL, range 78.8–2459.2 vs. median 116.1 pg/mL, range 40.7–1314.3, respectively; p < 0.001).

Figure 1. Maternal serum concentrations of CXCL10/IP-10 in patients with normal pregnancies and those with pyelonephritis. The median serum concentration of CXCL10/IP-10 in pregnant patients with pyelonephritis was significantly higher than in normal pregnant women (median 318.5 pg/mL, range 78.8–2459.2 vs. median 116.1 pg/mL, range 40.7–1314.3, respectively; p < 0.001).

Table I.  Clinical and obstetrical characteristics of the study groups

Figure 2. Maternal serum concentrations of CXCL10/IP-10 in patients with pyelonephritis. No significant differences in maternal median serum concentrations of CXCL10/IP-10 were observed between patients with positive and negative blood cultures (median 362.6 pg/mL, range 100.2–2459.2 vs. median 298.9 pg/mL, range 108.5–1148.7, respectively; p = 0.3).

Figure 2. Maternal serum concentrations of CXCL10/IP-10 in patients with pyelonephritis. No significant differences in maternal median serum concentrations of CXCL10/IP-10 were observed between patients with positive and negative blood cultures (median 362.6 pg/mL, range 100.2–2459.2 vs. median 298.9 pg/mL, range 108.5–1148.7, respectively; p = 0.3).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.